Rubin · Nature microbiology 2022 · In vitro experimental tool development and validation · n=?

Species- and site-specific genome editing in complex bacterial communities.

Cited 295 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Bench research and genetic tool development (Level 5 by design analogy, not clinical CEBM)

PubMed 34873292 · doi:10.1038/s41564-021-01014-7 · record verified 2026-08-29

What was done

Researchers developed and tested a two-part approach for editing genomes directly within mixed microbial communities. First, environmental transformation sequencing (ET-seq) was used to deliver non-targeted transposons into microbial communities (specifically soil and infant gut microbiota) to map and quantify genetically tractable member species. Second, DNA-editing all-in-one RNA-guided CRISPR-Cas transposase (DART) systems were deployed to perform targeted DNA insertions into specific genomic loci of the identified tractable organisms.

What was found

The abstract reports no numerical data or efficiency metrics. Qualitatively, the combination of ET-seq and DART successfully executed species- and site-specific genomic edits in several bacterial taxa within complex soil and infant gut communities, enabled gene fitness measurements in a non-model bacterium, and allowed targeted species enrichment.

Why it matters

Most microbes in natural communities remain uncultured, making traditional isolation-based genetic tools unusable. This platform provides a targeted method to interrogate gene function and manipulate specific bacteria in situ within complex microbial consortia.

Limits

The abstract provides no quantitative performance metrics, such as transformation efficiency, editing yield, or off-target rates. Testing was restricted to in vitro bench settings using soil and infant gut microbiota samples; performance, delivery barriers, and stability in live host environments were not assessed.

Cited by